Skip to main content

Table 2 Univariate Cox Regression Models of Relapse-free Survival and Overall Survival

From: Evaluation of six CTLA-4 polymorphisms in high-risk melanoma patients receiving adjuvant interferon therapy in the He13A/98 multicenter trial

  No of events/No of patients Median Relapse- free Survival (months) P value No of events/No of patients Median Overall Survival (months) P value
AG 49
A/A 71/132 59.56 0.55 47/132 NR* 0.55
A/G 70/128 46.42   47/128 84.20  
G/G 17/26 35.35   11/26 63.38  
CT 318
C/C 122/229 54.67 0.52 82/229 NR 0.36
C/T 34/55 47.67   21/55 NR  
T/T 2/2 37.35   2/2 51.02  
CT 60
A/A 34/65 58.87 0.68 23/65 NR 0.64
A/G 85/151 47.67   54/151 84.20  
G/G 39/70 53.22   28/70 76.68  
JO 27
C/C 37/73 58.87 0.60 26/73 NR 0.76
T/C 84/153 54.67   54/153 84.20  
T/T 37/60 37.29   25/60 76.68  
JO 30
A/A 37/72 56.71 0.65 27/72 NR 0.74
G/A 83/151 54.80   52/151 NR  
G/G 38/63 37.29   26/63 76.68  
JO 31
T/T 35/71 72.08 0.37 23/71 NR 0.50
G/T 85/151 47.67   56/151 80.69  
G/G 38/64 39.43   26/64 76.68  
  1. * NR: Not Reached